ALB and colonic neoplasm: One of these studies proposed HSA nanoparticles (HSA NPs) loaded with doxorubicin (DOX) and an antitumoral protein (TRIAL) (NPs size being about 120 nm) as vehicles for the delivery of DOX into colon tumor cells [9].